Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
$64.97
$64.81
$8.33
$65.00
$4.46B0.971.92 million shs2 shs
Enhabit, Inc. stock logo
EHAB
Enhabit
$7.71
-2.2%
$9.61
$6.85
$10.91
$399.02M1.72467,303 shs1.76 million shs
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$20.64
+5.0%
$19.49
$13.30
$30.03
$964.21M0.83296,437 shs947,025 shs
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$4.06
+0.2%
$3.93
$3.49
$9.24
$281.89M1.51611,236 shs593,938 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
0.00%0.00%0.00%0.00%0.00%
Enhabit, Inc. stock logo
EHAB
Enhabit
-1.66%-17.98%-25.51%-9.51%-11.99%
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
+5.04%-4.00%+7.84%+3.05%-4.88%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
+0.25%+7.69%+7.12%-1.93%-33.44%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
2.0311 of 5 stars
2.34.00.00.00.70.02.5
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
2.4731 of 5 stars
3.50.00.00.03.24.20.0
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
4.5886 of 5 stars
4.32.00.03.81.52.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
0.00
N/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
2.50
Moderate Buy$8.7513.49% Upside
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
3.00
Buy$41.2099.61% Upside
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.64
Moderate Buy$8.0097.04% Upside

Current Analyst Ratings Breakdown

Latest HCAT, ALPN, ELVN, and EHAB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$40.00 ➝ $48.00
6/17/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
6/16/2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$40.00 ➝ $52.00
6/16/2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$37.00
5/16/2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$36.00 ➝ $27.00
5/15/2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$39.00 ➝ $40.00
5/8/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $9.00
5/8/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$5.00 ➝ $5.50
4/25/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.00 ➝ $6.50
4/16/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$7.00 ➝ $5.00
4/9/2025
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Inline
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
$56.52M78.85N/AN/A$4.85 per share13.40
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.03B0.38$3.99 per share1.93$10.92 per share0.71
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
N/AN/AN/AN/A$6.34 per shareN/A
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$306.58M0.92$0.35 per share11.49$6.00 per share0.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
-$32.18M-$0.64N/AN/AN/A-65.17%-14.86%-11.82%N/A
Enhabit, Inc. stock logo
EHAB
Enhabit
-$156.20M-$2.77N/A26.59N/A-13.43%2.02%0.94%8/5/2025 (Estimated)
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
-$89.02M-$1.92N/AN/AN/AN/A-31.84%-30.09%8/12/2025 (Estimated)
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$69.50M-$1.15N/AN/AN/A-23.34%-6.14%-2.74%8/6/2025 (Estimated)

Latest HCAT, ALPN, ELVN, and EHAB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2025Q1 2025
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
-$0.51-$0.57-$0.06-$0.57N/AN/A
5/7/2025Q1 2025
Enhabit, Inc. stock logo
EHAB
Enhabit
$0.07$0.10+$0.03$0.35$266.11 million$259.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
N/AN/AN/AN/AN/A
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
N/AN/AN/AN/AN/A
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
N/A
9.56
9.56
Enhabit, Inc. stock logo
EHAB
Enhabit
0.82
1.49
1.49
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
N/A
21.07
21.06
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
0.40
1.24
1.24

Institutional Ownership

CompanyInstitutional Ownership
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
75.17%
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
95.08%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
85.00%

Insider Ownership

CompanyInsider Ownership
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
42.30%
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
25.90%
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
14268.60 million39.58 millionOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,70050.64 million48.92 millionOptionable
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
5049.07 million36.36 millionOptionable
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1,50069.60 million67.79 millionOptionable

Recent News About These Companies

Health Catalyst: Ignite Platform Is A Growth Catalyst
1 Mooning Stock Worth Your Attention and 2 to Avoid

New MarketBeat Followers Over Time

Media Sentiment Over Time

Alpine Immune Sciences stock logo

Alpine Immune Sciences NASDAQ:ALPN

Alpine Immune Sciences, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of immunotherapies through protein engineering technologies for treating autoimmune and inflammatory diseases. The company's product pipeline includes Povetacicept, a dual B cell cytokine antagonist, which is in Phase 2 clinical trial for the treatment of multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways that is in preclinical trial for the treatment of systemic lupus erythematosus. It is also developing RUBY-3 that has completed Phase 1 clinical trial for the treatment of glomerulonephritis; and RUBY-4, which has completed Phase 1 clinical trial for the treatment of cytopenias. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

Enhabit stock logo

Enhabit NYSE:EHAB

$7.71 -0.17 (-2.16%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$7.78 +0.07 (+0.92%)
As of 07/2/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

Enliven Therapeutics stock logo

Enliven Therapeutics NASDAQ:ELVN

$20.64 +0.99 (+5.04%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$20.64 0.00 (0.00%)
As of 07/2/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado.

Health Catalyst stock logo

Health Catalyst NASDAQ:HCAT

$4.06 +0.01 (+0.25%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$4.14 +0.08 (+2.07%)
As of 07/2/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.